Information  X 
Enter a valid email address

ShieldTherapeutics Ord1.5P (STX)

Date Time Source Announcement
17 Apr 2019 5:06 pm
RNS
Grant of share options
  5:01 pm
RNS
PDMR Acquisition of Shares and Additional Listing
  4:56 pm
RNS
PDMR Acquisition of Shares
11 Apr 2019 4:40 pm
RNS
Holding(s) in Company
08 Apr 2019 3:42 pm
RNS
Additional Listing
03 Apr 2019 7:00 am
RNS
Final Results
01 Apr 2019 5:44 pm
RNS
Additional Listing
  12:00 pm
RNS
Change of Adviser
27 Mar 2019 7:00 am
RNS
Notice of Results
14 Mar 2019 3:31 pm
RNS
Positive decision on Feraccru?'s process patent
04 Mar 2019 7:00 am
RNS
Positive results for Feraccru? in AEGIS-H2H study
29 Jan 2019 7:00 am
RNS
Positive results of AEGIS-CKD study
28 Jan 2019 7:15 am
EQS
Shield Therapeutics (STX): Cast-iron investment
24 Jan 2019 7:00 am
RNS
Business and trading update
23 Jan 2019 10:19 am
RNS
Investor presentations
22 Jan 2019 7:00 am
RNS
Appointment of Chairman
13 Dec 2018 7:00 am
RNS
US New Drug Application PDUFA date for Feraccru
05 Dec 2018 10:04 am
RNS
UK launch of Feraccru? by Norgine
03 Dec 2018 7:00 am
RNS
New Drug Application for Feraccru?
09 Nov 2018 3:46 pm
RNS
Holding(s) in Company
08 Nov 2018 6:21 pm
RNS
Holding(s) in Company
01 Oct 2018 1:54 pm
RNS
Notification Of Major Holdings
  7:00 am
RNS
Submission of an NDA for Feraccru? with the FDA
24 Sep 2018 1:06 pm
RNS
Director/PDMR Shareholding
  1:02 pm
RNS
Holding(s) in Company
19 Sep 2018 7:14 am
RNS
Licence for the commercialisation of Feraccru
  7:12 am
RNS
Interim Results
13 Sep 2018 7:00 am
RNS
AEGIS-H2H Completion of Recruitment
26 Jul 2018 7:00 am
RNS
Appointment of Non-Executive Director
23 Jul 2018 7:00 am
RNS
Business Update
09 Jul 2018 4:27 pm
RNS
Holdings in Company
  4:26 pm
RNS
Holdings in Company
28 Jun 2018 11:56 am
RNS
Result of AGM
  7:00 am
RNS
Data from real-world clinical use of Feraccru
14 Jun 2018 7:00 am
RNS
Positive top-line results from AEGIS-PAED PK study
05 Jun 2018 7:00 am
RNS
Directorate Change
  7:00 am
RNS
2017 Annual Report and 2018 AGM Notice
15 May 2018 6:21 pm
RNS
Grant of share options
04 May 2018 9:20 am
RNS
Holding(s) in Company
03 May 2018 5:26 pm
RNS
Holding(s) in Company
02 May 2018 11:00 am
RNS
Price Monitoring Extension
11 Apr 2018 7:00 am
RNS
Preliminary Results for the Year Ended 31 Dec 17
06 Apr 2018 7:00 am
RNS
Appointment of Non-Executive Director
  7:00 am
RNS
Results of Pre-Submission Meeting with FDA
27 Mar 2018 7:00 am
RNS
Broadening of Feraccru indication
16 Mar 2018 7:00 am
RNS
Update on the AEGIS-CKD study
23 Feb 2018 1:56 pm
RNS
Receives CHMP positive opinion on Feraccru?
22 Feb 2018 7:00 am
RNS
Business and Trading Update
05 Feb 2018 7:00 am
RNS
Top-line results from Feraccru Phase III study
29 Jan 2018 7:00 am
RNS
Notice of Results
25 Jan 2018 7:00 am
RNS
Grant of share options
10 Oct 2017 7:00 am
RNS
Completion of patient enrolment in Phase 3 study
05 Oct 2017 7:00 am
RNS
PDMR Acquisition of Shares
20 Sep 2017 7:00 am
RNS
Interim Report
14 Sep 2017 7:00 am
RNS
Board Change
06 Sep 2017 7:00 am
RNS
US Composition of Matter Patent Allowed
31 Aug 2017 7:00 am
RNS
Shield to Present at Baird Healthcare Conference
15 Aug 2017 7:00 am
RNS
Notice of Results
11 Jul 2017 2:59 pm
RNS
Grant of Share Options
10 Jul 2017 4:16 pm
RNS
Holding(s) in Company
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t